List of Studies ( Metabolite:3-Hydroxycaproic acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004186 | AN007232 | Discovery and Validation of Metabolic Biomarkers for 'Liver Qi Stagnation' and 'Liver-Gallbladder Damp-Heat' Syndromes in Cholelithiasis: Blood untargeted | Blood | Human | Gallstones | First Affiliated Hospital of Dalian Medical University | LC-MS |
| ST004082 | AN006760 | The secreted metabolite sensor CtBP2 links metabolism to healthy lifespan | Fibroblast cells | Human | University of Tsukuba | CE-MS | |
| ST003931 | AN006454 | Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-neg, C8-pos and C18-neg profiling of mouse fecal samples | Feces | Mouse | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006420 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Bifidobacteria | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006420 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Clostridium | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006420 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Escherichia coli | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006420 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Streptococcus | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003348 | AN005484 | An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - untargeted | Blood | Human | First Affiliated Hospital of Dalian Medical University | LC-MS | |
| ST001610 | AN002644 | Control (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hours | Lung | Human | Cancer | Ohio University | LC-MS |
| ST000549 | AN000838 | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Blood | Mouse | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000670 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000664 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |